Effects of AT1 receptor antagonist, losartan, on rat hepatic fibrosis induced by CCl4

doi:10.3748/wjg.v6.i4.540

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2109)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

247

HTML

1561

Figures (1-3)

178

Tables (1-3)

123

Sum=2109

Aug 15, 2000 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Articles

World J Gastroenterol. Aug 15, 2000; 6(4): 540-545
Published online Aug 15, 2000. doi: 10.3748/wjg.v6.i4.540

Full Size Figure Download Figure

Figure 3 TGF-β expression in liver section of model rat ( DAB staining, × 200). TGF-β expression is seen scattered in the fibrotic areas and vascular wall (A), and of losart an treated group (DAB staining, × 200). Note significantly less TGF-β expression than that seen in the model group (B).

Citation: Wei HS, Li DG, Lu HM, Zhan YT, Wang ZR, Huang X, Zhang J, Cheng JL, Xu QF. Effects of AT1 receptor antagonist, losartan, on rat hepatic fibrosis induced by CCl₄. World J Gastroenterol 2000; 6(4): 540-545
URL: https://www.wjgnet.com/1007-9327/full/v6/i4/540.htm
DOI: https://dx.doi.org/10.3748/wjg.v6.i4.540